NLRC5 deficiency ameliorates diabetic nephropathy through alleviating inflammation.
Luan P, Zhuang J, Zou J, Li H, Shuai P, Xu X, Zhao Y, Kou W, Ji S, Peng A, Xu Y, Su Q, Jian W, Peng W.
Luan P, et al. Among authors: shuai p.
FASEB J. 2018 Feb;32(2):1070-1084. doi: 10.1096/fj.201700511RR. Epub 2018 Jan 3.
FASEB J. 2018.
PMID: 29070585
NLRC5 may, therefore, be a promising therapeutic target for DN treatment.-Luan, P., Zhuang, J., Zou, J., Li, H., Shuai, P., Xu, X., Zhao, Y., Kou, W., Ji, S., Peng, A., Xu, Y., Su, Q., Jian, W., Peng, W. ...
NLRC5 may, therefore, be a promising therapeutic target for DN treatment.-Luan, P., Zhuang, J., Zou, J., Li, H., Shuai, P …